<DOC>
	<DOCNO>NCT01876615</DOCNO>
	<brief_summary>The objective study compare pharmacokinetics single oral administration YH4808 Diclofenac separately versus coadministration YH4808 Diclofenac healthy male volunteer</brief_summary>
	<brief_title>Pharmacokinetic Drug Interaction Between YH4808 Diclofenac</brief_title>
	<detailed_description />
	<mesh_term>Diclofenac</mesh_term>
	<criteria>healthy male age 20 45 55kg Ideal body weight ( IBW ) No clinically important abnormal physical finding screen examination Subject congential , chronic disease disease symptoms medical examination result Subject judge eligible principal inverstigator subinvestigator accord various reason includiong ther abnorminal test result ( clinical laboratory test , 12lead GCG etc ) Ability communicate well inverstigator comply requremetns entire study Willingness give write informed consent ( prior studyrelated procedure be perform ) able adhere study restriction examination schedule Suject history presence clinically significant disease liver , kidney , gastrointestinal tract , nervous system , respiratory system , endocrine system , blood tumor , cardiovascular , urinary system , mental disorder Subject hypersensitive component contain YH4808 declofenac related drug ( ex . rebamipide , revaprazan , NSID etc ) Medical history gastrointestinal disease acid restrain surgery , gastric/ esophagus surgery ( exclude appendectomy , hernia surgery ) Subject history drug dependence use drug Subject take usual dose prescription durgs within 14 day treatment use usual dose OTC drug within 7 day treatment Subject participate antoher clinical trial within 2 monthes enrol study subject donate whole blood within 2 month component blood within 1 month treatment Subject drink 21unit/week ( 1 unit= 10g alcohol ) able refrain drinking alcohol study day Subject stop smoke within 3 month treatment detect cotinine urine test Subject clinically significant observation consider unsuitable base medical judgment investigator</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>safety/tolerability pharmacokinetics/pharmacodynamics</keyword>
</DOC>